Target intelligence / Profile preview

Vaginal epithelial tissue (None commonly used)

Target
None commonly used
Molecular classification
Other (Tissue/epithelial barrier), Non-keratinized stratified squamous epithelium
01

Overview

The **vaginal epithelial tissue**, also known as the vaginal epithelium, forms the innermost lining of the vagina. It consists primarily of nonkeratinized stratified squamous epithelial cells arranged in several layers—basal, parabasal, intermediate, and superficial—which provide protection against mechanical stress during intercourse and childbirth while serving as a physical barrier against pathogens. This layer is highly sensitive to estrogen; under its influence, it thickens and accumulates glycogen that supports beneficial lactobacilli responsible for maintaining acidic pH. The permeability allows immune components such as antibodies and white blood cells access to defend against infection. Regular exfoliation helps remove potential pathogens from the lumen. The health status and thickness can be assessed using cytologic indices like VMI; atrophy occurs with declining estrogen levels after menopause or certain medical conditions.

Other names
Vaginal epitheliumVaginal mucosaStratified squamous epithelium of the vagina
02

Mechanism of action

Not applicable as there is no single mechanism; mechanisms depend on drug class: Estrogens stimulate proliferation/thickening via estrogen receptors in epithelial cells. Antimicrobials disrupt microbial growth on/within the mucosa.

03

Biological functions

Physical barrier against pathogensImmune defense (permeable to immune cells and antibodies)Maintenance of vaginal pH via glycogen metabolism supporting lactobacilliProtection during intercourse and childbirth through elasticity and resilienceExfoliation for removal of pathogens
04

Disease associations

Infection (site for sexually transmitted infections)Cancer (vaginal cancer arises from this tissue)Inflammation (vaginitis)
05

Safety considerations

As an administration site: Local irritation/inflammation from topical agentsAs an administration site: Disruption of normal flora leading to secondary infectionsAs biological function: Thinning/atrophy increases infection risk post-menopause due to low estrogen levels
06

Interacting drugs

Topical estrogens

3 more in the full profile.

07

Biomarkers

Vaginal maturation index (VMI): cytologic assessment reflecting hormonal status by quantifying cell types present in smears from the vaginal epitheliumNo direct biomarkers exist for "target engagement" with this tissue

Beyond the preview

Go deeper on Vaginal epithelial tissue (None commonly used).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal epithelial tissue (None commonly used).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call